logo

TGA Compliance Information

Last Updated:

Therapeutic Goods Administration (TGA) Compliance

Zibralonstshexio is committed to compliance with Australian regulations governing complementary medicines. Our products are manufactured and supplied in accordance with the Therapeutic Goods Administration (TGA) requirements.

Product Listing

BOTANICARE BLISS is listed with the Therapeutic Goods Administration (TGA) as a listed complementary medicine. Listed medicines are assessed by the TGA for quality and safety, but not for efficacy. This means:

  • The product meets TGA quality and safety standards
  • The product is manufactured in TGA-licensed facilities
  • The product contains only permitted ingredients
  • All claims made about the product are within permitted indications

Permitted Indications

Listed complementary medicines may only make low-level health claims that are included in the TGA's Permitted Indications List. Our product claims are limited to:

  • General wellbeing and health maintenance
  • Supporting general health and vitality
  • Complementing a healthy lifestyle

We do not make therapeutic claims about treating, preventing, or curing diseases or medical conditions.

Manufacturing Standards

Our products are manufactured in facilities that:

  • Hold a TGA manufacturing licence
  • Comply with Good Manufacturing Practice (GMP) requirements
  • Undergo regular TGA inspections
  • Maintain strict quality control procedures
  • Conduct batch testing and quality assurance

Adverse Event Reporting

We take product safety seriously. If you experience any adverse effects while using our products, please:

  • Stop using the product immediately
  • Consult your healthcare professional
  • Report the adverse event to us at clients@zibralonstshexio.world
  • Report to the TGA via their website if necessary

Important Information

This product is not a medicine. It is a complementary medicine listed with the TGA.

This product is not intended to diagnose, treat, cure, or prevent any disease.

Always read the label and follow directions for use.

If symptoms persist, talk to your healthcare professional.

This product is not suitable for children, pregnant or breastfeeding women, or individuals with known medical conditions without consulting a healthcare professional first.

Contact Information

For questions about TGA compliance or product safety, please contact us:

Email: clients@zibralonstshexio.world
Address: Level 5/40 St Georges Terrace, Perth WA 6000, Australia
Phone: +611300642462

For more information about TGA regulations, visit: www.tga.gov.au